Dec 15 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling drug Biktarvy in a late-stage ...

Charlie Sheen fans know to always expect the unexpected when it comes to the legendary actor. He can be unfiltered so you just never know what the guy might say. Which brings us to his recent ...

I’ve spent much of my career caring for people in places most Americans never see. I’ve worked in refugee camps, on the streets of large cities, in rural communities cut off from care, in clinics ...

Though Charlie Sheen's HIV status has been "completely manageable," the award-winning actor said he once found a "really good" solution that never came to fruition. During an appearance on the "Howie ...

On World AIDS Day, advocates warn federal cuts could reverse progress. Carole Treston had been a nurse early in her career when she and her mother traveled to Washington, D.C., and saw the AIDS ...

A man has become the seventh person to be left HIV-free after receiving a stem cell transplant to treat blood cancer. Significantly, he is also the second of the seven who received stem cells that ...

A small, highly anticipated study shows a glimmer of hope in the long effort to control HIV without medication and search for a cure for a virus that attacks immune cells. Researchers gave 10 people ...

People infected with HIV must take antiretroviral drugs for life. But promising trials using engineered antibodies suggest that "functional cures" may be in reach. When you purchase through links on ...

South Africa, Eswatini and Zambia on Monday began administering a groundbreaking HIV-prevention injection in the drug's first public rollouts in Africa, which has the world's highest HIV burden.

Global Fund Executive Director Peter Sands inspects boxes with lenacapavir during a visit to Eswatini’s Central Medical Stores. When I walked into Eswatini’s Central Medical Stores that morning, the ...

Nov 19 (Reuters) - Merck (MRK.N), opens new tab said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' (GILD.O), opens new tab top-selling drug Biktarvy ...

Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval molecule as a new anchor treatment for the infectious disease. Integrase strand ...